GALE Overview
Upcoming Projects (GALE)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (GALE)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (GALE)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (GALE)
-
Phase 3 final endpoint of NeuVax (E75) for low-to-intermediate HER2+ breast cancer is expected to be reached in 2018 - Terminated
Tickers: SLS, GALE
Occurred on: Jun 01, 2018 -
Phase 2a two-year data of GALE-301 for ovarian cancer due Q4 2016
Ticker: GALE
Occurred on: Mar 17, 2017 -
U.S Department of Justice Launches Criminal Investigation of Galena (GALE) Related to Opioid Abstral Promotional Practices
Ticker: GALE
Occurred on: Jan 09, 2017 -
Galena Biopharma (GALE) Presents GALE-301/GALE-302 Phase 1b Data
Ticker: GALE
Occurred on: Nov 14, 2016 -
Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress
Ticker: GALE
Occurred on: Jun 13, 2016 -
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Ticker: GALE
Occurred on: Jun 10, 2016 -
Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016
Ticker: GALE
Occurred on: Jun 06, 2016 -
Galena Biopharma Receives Fast Track Designation for NeuVax (nelipepimut-S) PRESENT Clinical Trial
Ticker: GALE
Occurred on: Jun 01, 2016 -
Galena Biopharma commences a public offering of common stock and warrants
Ticker: GALE
Occurred on: Jan 06, 2016 -
Midatech completes acquisition of Zuplenz(ondansetron) from Galena Biopharma
Tickers: MTP, GALE
Occurred on: Dec 30, 2015
Strategic Initiatives (GALE)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
